← Back to headlines
RBC Nudges Vertex Pharmaceuticals Price Target Higher Amid Biotech Outlook Update
RBC Capital Markets has increased its price target for Vertex Pharmaceuticals (VRTX) as it updates its outlook for the biotech sector. This reflects a positive analyst sentiment towards the company.
24 Apr, 13:40 — 24 Apr, 13:40
Sources
Showing 1 of 1 sources
